LiveActive security incident?Get immediate response
CVE Record

CVE-2020-16237: Philips SureSigns VS4 Improper Input Validation

Philips SureSigns VS4, A.07.107 and prior receives input or data, but it does not validate or incorrectly validates that the input has the properties required to process the data safely and correctly.

LowCVSS 2.1Not KEV-listedUpdated
Glexia's TakeAutomated analysislow

Security readout for executives and security teams

Plain-English summary

CVE-2020-16237 is a low-severity input validation issue in Philips SureSigns VS4 patient monitors, A.07.107 and prior. The available scoring indicates an attacker needs physical access and low privileges, with only limited availability impact and no stated data theft or integrity impact.

Executive priority

Treat this as a low-priority medical-device hygiene item unless affected monitors are widely deployed or physically accessible to untrusted people. Address through biomedical asset management and vendor-supported remediation, not emergency response.

Technical view

The issue is CWE-20 improper input validation. CVSS 3.1 is 2.1 with AV:P/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L, meaning exploitation requires physical access and a low-privileged position. Public source details do not describe a specific vulnerable input, exploit method, or confirmed fix.

Likely exposure

Exposure is most relevant to healthcare environments that still operate Philips SureSigns VS4 devices on A.07.107 or earlier. Internet exposure is not supported by the CVSS vector or provided sources.

Exploitation context

The source bundle does not show CISA KEV listing or active exploitation evidence. The CVSS vector indicates local physical access is required, reducing broad remote attack risk but keeping device-room and service-access controls relevant.

Researcher notes

Evidence is limited to the CVE description, CVSS vector, CWE-20 classification, and advisory references. No public exploit details, affected input path, or patch version is included in the supplied bundle.

Mitigation direction

  • Confirm whether any SureSigns VS4 units run A.07.107 or earlier.
  • Review Philips and CISA ICS guidance before changing clinical devices.
  • Limit physical access to affected monitors and service interfaces.
  • Coordinate remediation windows with biomedical engineering and patient-care operations.
  • Track vendor advisories for replacement, configuration, or service actions.

Validation and detection

  • Inventory Philips SureSigns VS4 assets and record firmware/software versions.
  • Compare observed versions with A.07.107 and prior.
  • Confirm affected devices are protected from unauthorized physical access.
  • Review CISA and Philips advisories for remediation language.
  • Document any unsupported or end-of-life device constraints.
Prepared
Confidence
medium
Sources
4

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cwe · low confidence lookup

CWE-20: Exact CWE lookup

Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2020-16237 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Low
CVSS
2.1 (3.1)
Known Exploited
No
Published

Vector: CVSS:3.1/AV:P/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L

Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

1CVSS vectors
0Timeline events
0ADP providers
3Source links

CVSS vector scores

1 official score

We collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.

ScoreVersionSeverityVectorExploitImpactSource
2.1CVSS 3.1LowCVSS:3.1/AV:P/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L0.71.4Primary CVE score

Vulnerability scoring details

Base CVSS 3.1 score

2.1Low
CVSS 3.1 vector shape for CVE-2020-16237Attack VectorAttack ComplexityPrivileges RequiredUser InteractionScopeConfidentiality ImpactIntegrity ImpactAvailability Impact

Vector: CVSS:3.1/AV:P/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L

Attack Vector
NetworkAdjacentLocalPhysical
Attack Complexity
LowHigh
Privileges Required
NoneLowHigh
User Interaction
NoneRequired
Scope
ChangedUnchanged
Confidentiality Impact
HighLowNone
Integrity Impact
HighLowNone
Availability Impact
HighLowNone
Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
PhilipsSureSigns VS40unaffected
Weakness

CWE details

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.